Pruebe esto primero
La hidratante que ya usa
Nuestra búsqueda no encontró ningún ensayo controlado que muestre que alguna de estas tres supere a una hidratante corriente alrededor de los ojos.
Una categoría sin pruebas
Tres cremas para el contorno de ojos
Qué le ofrece esta página: Si una crema de ojos supera a la hidratante que ya tiene y qué declaran de verdad estas etiquetas.
La respuesta corta
Qué hacer después
Si aun así quiere una crema de ojos, compare el precio del envase y los ingredientes declarados. Solo Avène indica la concentración de su activo.
Lo que esta página no puede decirle
CeraVe se vende por peso y las otras dos por volumen, así que no es posible comparar de forma justa el precio por mililitro entre las tres.
Los tres productos
Los precios son una observación fechada, no una oferta vigente.
Vendida por peso · ceramidas y cafeína
CeraVe Eye Repair Cream
$1.97 por g14.2 g tube
Ver la verificación de la fórmula (en inglés)
Leímos la lista de ingredientes del envase de este mercado · comprobado el 2026-08-23
Fragrance-free per the published list; contains sweet almond oil (nut-derived).
La única que declara la concentración de un activo
Avène Hyaluron Activ Retinal 0.05% Eye & Lip Cream
$5.27 por mLretinaldehyde 0.05% + niacinamide 2% · 15 mL tube
Ver la verificación de la fórmula (en inglés)
Leímos la lista de ingredientes del envase de este mercado · comprobado el 2026-08-23
Replaces the RetrinAL Eyes cream we used (no longer sold in Canada).
Para piel muy sensible
La Roche-Posay Toleriane Dermallergo Eyes
$1.95 por mL20 mL tube
Ver la verificación de la fórmula (en inglés)
Leímos la lista de ingredientes del envase de este mercado · comprobado el 2026-08-23
The renamed replacement for the Toleriane Ultra eye cream we used; our "no clear difference" impression was of that older tube, not this one.
Qué cambiaOnly the Avène declares an active strength. CeraVe lists its package by mass while the other two use volume, so a three-way per-millilitre comparison would require an unreported product density.
Las verificaciones, lado a lado
One question per row. The green check marks that row's better answer — there is no overall winner.
| Verificación | CeraVeEye Repair Cream | AvèneRetinal 0.05% Eye & Lip | La Roche-PosayDermallergo Eyes |
|---|---|---|---|
| Proof it beats a plain moisturizerindependent trials · Aug 20, 2026 | —no comparison identified in maintained sources as of Aug 20, 2026 | —no comparison identified in maintained sources as of Aug 20, 2026 | —no comparison identified in maintained sources as of Aug 20, 2026 |
| What's declared insideactive strengths on the label | No strengths on checked labelceramides, niacinamide, caffeine | 0.05% retinaldehydeplus 2% niacinamide | No strengths on checked labela probiotic extract + niacinamide |
Todo lo anterior en detalle: las verificaciones lado a lado, lo que halló cada estudio, lo que dicen las etiquetas y nuestras fuentes.
La evidencia detallada que sigue está escrita en inglés.
Por qué esta respuesta
Resumen de la comparación
Does any eye cream beat a plain moisturizer?
The maintained sources through Aug 23, 2026 identified no controlled trial showing that one of these eye creams outperforms a regular moisturizer around the eyes. If you want one anyway, compare the package prices and declared ingredients: only the Avène states the strength of its retinaldehyde. CeraVe is sold by mass, so it is not converted to millilitres.
Qué coincide
All three are fragrance-free eye-area creams from drugstore skincare brands.
Qué cambia
Only the Avène declares an active strength. CeraVe lists its package by mass while the other two use volume, so a three-way per-millilitre comparison would require an unreported product density.
Límite de la evidencia
Evidence on this page supports the ingredient, product type, or prevention step. It doesn't prove any one of these exact products is better.
Lo que los estudios encontraron de verdad
The evidence differs by product. CeraVe and Avène evidence is about other products or facial use; Toleriane Dermallergo Eyes has exact-product studies, but the available studies are manufacturer-linked and do not include a comparison group.
~The brand has studies, but none of this product
CeraVe Eye Repair Cream
Twenty-five registered studies name a CeraVe product. None names the Eye Repair Cream, and it appears in none of the 153 PubMed records that mention CeraVe. The largest is a 528-person study at the University of Miami that tested the CeraVe Hydrating Cleanser and Moisturizing Cream, twice daily for 28 days, in people with diabetes-related skin changes. At day 33 the treating physicians rated 447 of 528 much or very much improved.
Salvedad: That study had one group, nothing to compare it against, and everyone knew what they were using; the rating was the treating physician's own judgment, and CeraVe was a named partner on it.
~The brand tested a different cream, not this one
Avène Hyaluron Activ Retinal 0.05% Eye & Lip Cream
The maintained ClinicalTrials.gov and PubMed searches returned no record naming this eye and lip cream. Avène's parent company did register and publish a randomized split-face study of a different retinaldehyde face cream in 66 people over three months, entered under the internal code RV4983A rather than a product name. A separate 44-week trial in 125 people, comparing it against the same cream base without the active ingredient, studied 0.05% retinaldehyde on facial skin, but a later critical review found no retinaldehyde-versus-plain-base difference it could tell apart from chance for wrinkle depth or roughness.
Salvedad: Neither study tested this current eye-and-lip formula or the eye area. The split-face study used no placebo, the 1998 authors included manufacturer staff, and within-group improvement is not proof of a between-group benefit.
Critical review of randomized topical retinoid trials, 2021 ↗Retinaldehyde trial record →
✓This product was studied, but with nothing to compare it against
La Roche-Posay Toleriane Dermallergo Eyes
A published study, in which everyone knew what they were using, identified Toleriane Dermallergo Eye Cream by name and followed 41 adults with eyelid eczema who used it twice daily for 28 days. Mean DLQI improved from 4.17±2.23 to 0.82±1.0; usual skincare was allowed, there was no control group, and no local adverse reactions were reported in that study. A 2026 case report (doi:10.1111/cod.70122) later attributed allergic eyelid contact eczema from this product to hydroxyacetophenone.
Salvedad: The 41-person study had no control group, four of five authors worked for La Roche-Posay, and the remaining author reported company fees. The later allergy report is one case and cannot estimate incidence. Neither record establishes superiority to a plain moisturizer or benefits for dark circles or wrinkles.
Tan et al., Clinical, Cosmetic and Investigational Dermatology, 2023 ↗
Otras fuentes consultadas
Exact-product searches were checked through August 23, 2026, and additional evidence was reviewed through August 25. Dermallergo Eyes has exact-product evidence, but it is uncontrolled and manufacturer-linked; a later single allergy case is a tolerability signal, not an incidence estimate. No maintained source establishes that any of the three products is better than a plain moisturizer or either alternative for cosmetic eye-area outcomes.
Cómo buscamos estudios sobre estos productos exactos
Última búsqueda:
Última revisión de los resultados:
For each evidence row, search the quoted evidence-row product name, then the quoted brand plus the distinctive product-name tokens. A brand-wide statement additionally requires a quoted brand-name search. Formula codes are added only when an official or study source discloses them.
- ClinicalTrials.gov: Registered studies returned by exact product-name, brand-plus-product-name, and disclosed internal formula-code searches.
- PubMed: Indexed records returned by exact product-name and brand-plus-distinctive-product-token searches.
Lo que esto no le dice: A negative maintained search is a dated coverage statement, not proof that no study exists in another database, language, registry, sponsor archive, unpublished report, or differently named formula.
Notas y fuentes
- No controlled exact-product study here establishes superiority over a plain moisturizer, but product-adjacent evidence is not absent. A sponsored 41-person open-label Dermallergo eyelid study reported DLQI improving from 4.17 to 0.82 over 28 days; usual skincare was allowed and there was no comparator. No local reaction occurred in that study, while a later single case report attributed allergic eyelid contact eczema from this product to hydroxyacetophenone. One case cannot estimate incidence.
- The retinaldehyde eye-area study that exists had no comparison group, everyone knew what they were using, 33 people, 8 weeks, and it was run by researchers tied to the maker. Facial retinaldehyde trials involve another site and formula; in the main 125-person vehicle-controlled trial, a critical review found no statistically significant 0.05% retinaldehyde-versus-vehicle difference for wrinkle depth or roughness.
- We used Avène RetrinAL Eyes and La Roche-Posay's Toleriane Ultra eye cream; both lines have been replaced in Canada — the products here are their current successors (Avène's declares 0.05% retinaldehyde; La Roche-Posay's is now named Dermallergo).
- Avène's $79.00 regular price is listed; a $63.20 sale was ending the day we checked. CeraVe's package is labelled in grams. No product density was captured, so its mass is not converted to millilitres and its unit cost is reported per gram.
- ClinicalTrials.gov and PubMed searches through Aug 23, 2026 identified no head-to-head study of these exact products.
Después de la evidencia
Ver precios actuales en Amazon
Como afiliado de Amazon, Skinlogie obtiene ingresos por compras que cumplen los requisitos, sin costo adicional para usted. Los enlaces llevan a fichas exactas cuando están verificadas.